[Effective also in Bechterew disease].
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D000068579:Celecoxib; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004008:Diclofenac / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D026741:Physical Therapy Modalities; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011720:Pyrazoles; D013449:Sulfonamides; D004008:Diclofenac; D000068579:Celecoxib